Archive
A tighter archive for life-science signals.
Search once, then narrow by source or topic.
$19.8 Billion Cell and Gene Therapy Tools & Reagents Market Outlook, 2030 Featuring Thermo Fisher Scientific, Cytiva (Danaher), Merck, Miltenyi Biotec, Sartorius and More - Yahoo Finance
$19.8 Billion Cell and Gene Therapy Tools & Reagents Market Outlook, 2030 Featuring Thermo Fisher Scientific, Cytiva (Danaher), Merck, Miltenyi Biotec, Sartorius and Mo...
Danaher buys patient monitoring specialist Masimo in $9.9B deal
Danaher buys patient monitoring specialist Masimo in $9.9B deal
Danaher Said to Be Near $10 Billion Deal to Buy Masimo, FT Says - Bloomberg.com
Danaher Said to Be Near $10 Billion Deal to Buy Masimo, FT Says - Bloomberg.com
Agilent, Danaher could be potential buyers of Qiagen - analyst (QGEN:NYSE) - Seeking Alpha
Agilent, Danaher could be potential buyers of Qiagen - analyst (QGEN:NYSE) - Seeking Alpha
Agilent, Danaher, Thermo Fisher new buys at Goldman Sachs (A:NYSE) - Seeking Alpha
Agilent, Danaher, Thermo Fisher new buys at Goldman Sachs (A:NYSE) - Seeking Alpha
Molecular Cytogenetics Market Intelligence Report (2020-2030) Featuring Key Players Danaher, MetaSystems, Agilent Technologies, Abbott Labs, Bio-Rad Labs and More - ResearchAndMarkets.com - The AI Journal
Molecular Cytogenetics Market Intelligence Report (2020-2030) Featuring Key Players Danaher, MetaSystems, Agilent Technologies, Abbott Labs, Bio-Rad Labs and More - Res...
North America Mass Spectrometry Market Report 2025-2033, Profiles of Agilent Technologies, Bruker, Danaher, Hitachi, JEOL, LECO, PerkinElmer, and Thermo Fisher Scientific - Yahoo Finance UK
North America Mass Spectrometry Market Report 2025-2033, Profiles of Agilent Technologies, Bruker, Danaher, Hitachi, JEOL, LECO, PerkinElmer, and Thermo Fisher Scientif...
Danaher and Shanghai biotech company announce strategic partnership - China Daily
Danaher and Shanghai biotech company announce strategic partnership China Daily
Nuclera and Danaher-owned US ally boost protein proposition - Business Weekly
Nuclera and Danaher-owned US ally boost protein proposition Business Weekly
Introducing Cytiva: GE plans name change ahead of $21bn Danaher buy - BioProcess International
Introducing Cytiva: GE plans name change ahead of $21bn Danaher buy BioProcess International
‘Better together’ – Danaher completes Cytiva Pall merger - BioProcess International
‘Better together’ – Danaher completes Cytiva Pall merger BioProcess International
Danaher merging Cytiva and Pall - BioProcess Insider - BioProcess International
Danaher merging Cytiva and Pall - BioProcess Insider BioProcess International
Danaher Delivers: Cytiva, Pall Plan $1.5B Manufacturing Expansion - GEN - Genetic Engineering and Biotechnology News
Danaher Delivers: Cytiva, Pall Plan $1.5B Manufacturing Expansion GEN - Genetic Engineering and Biotechnology News
Cytiva rises out of GE Healthcare as Danaher completes $21bn deal - BioProcess International
Cytiva rises out of GE Healthcare as Danaher completes $21bn deal BioProcess International
Directory ribbon
Brand directory, kept in view
A rolling strip of the companies, platforms, CROs and device makers that show up across the coverage.
Open about page